Prelude Therapeutics IncorporatedPRLD 
$1.19-4.03%24h
-4.03%24h
Global rank23340
Market cap$49.96M
Change 7d49.31%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings-$121.83M
Dividend yield-
Main Sector
Healthcare
Prelude Therapeutics Incorporated Revenue data
According to Prelude Therapeutics Incorporated latest financial reports the company had revenue of $0 in 2023-12-31, a NaN% decrease from 2022. Prelude Therapeutics Incorporated highest revenue was $0 in 2023.
Revenue history for Prelude Therapeutics Incorporated from 2020 to 2025
-
Value:-
Prelude Therapeutics Incorporated revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $0 | NaN% |
| 2022 | $0 | NaN% |
| 2021 | $0 | NaN% |
| 2020 | $0 | - |
View the top revenue stocks 
